Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Is it safe to irradiate the newest generation of ventricular assist devices? A case report and systematic literature review.

Spano G, Stutz E, Elicin O, Hugi B, Henzen D, F├╝rholz M, Wieser M, Rhyner D, Dobner S, Pavlicek-Bahlo M, Robson D, Nadel J, Hayward C, Hunziker L, Martinelli M, Schnegg B.

Artif Organs. 2019 Nov 26. doi: 10.1111/aor.13612. [Epub ahead of print] Review.

PMID:
31769042
2.

Bridge to Transplantation With Long-Term Mechanical Assist Devices in Adults With Transposition of the Great Arteries.

Michel E, Orozco Hernandez E, Enter D, Monge M, Nakano J, Rich J, Anderson A, Backer C, McCarthy P, Pham D.

Artif Organs. 2019 Jan;43(1):90-96. doi: 10.1111/aor.13347. Epub 2018 Oct 28.

PMID:
30129258
3.

Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.

Uriel N, Colombo PC, Cleveland JC, Long JW, Salerno C, Goldstein DJ, Patel CB, Ewald GA, Tatooles AJ, Silvestry SC, John R, Caldeira C, Jeevanandam V, Boyle AJ, Sundareswaran KS, Sood P, Mehra MR.

Circulation. 2017 May 23;135(21):2003-2012. doi: 10.1161/CIRCULATIONAHA.117.028303. Epub 2017 Apr 6.

PMID:
28385948
4.

Quality of life and functional capacity outcomes in the MOMENTUM 3 trial at 6 months: A call for new metrics for left ventricular assist device patients.

Cowger JA, Naka Y, Aaronson KD, Horstmanshof D, Gulati S, Rinde-Hoffman D, Pinney S, Adatya S, Farrar DJ, Jorde UP; MOMENTUM 3 Investigators.

J Heart Lung Transplant. 2018 Jan;37(1):15-24. doi: 10.1016/j.healun.2017.10.019. Epub 2017 Oct 24.

PMID:
29153637
5.

Early outcomes with durable left ventricular assist device replacement using the HeartMate 3.

Barac YD, Wojnarski CM, Junpaparp P, Jawitz OK, Billard H, Daneshmand MA, Agrawal R, Devore A, Patel CB, Schroder JN, Milano CA.

J Thorac Cardiovasc Surg. 2019 Oct 16. pii: S0022-5223(19)32208-1. doi: 10.1016/j.jtcvs.2019.09.151. [Epub ahead of print]

PMID:
31740114
6.

Left ventricular assist devices: an evidence-based analysis.

Medical Advisory Secretariat.

Ont Health Technol Assess Ser. 2004;4(3):1-69. Epub 2004 Mar 1.

7.

Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial.

Bansal A, Uriel N, Colombo PC, Narisetty K, Long JW, Bhimaraj A, Cleveland JC Jr, Goldstein DJ, Stulak JM, Najjar SS, Lanfear DE, Adler ED, Dembitsky WP, Somo SI, Crandall DL, Chen D, Connors JM, Mehra MR.

J Heart Lung Transplant. 2019 Aug;38(8):806-816. doi: 10.1016/j.healun.2019.05.006. Epub 2019 May 17.

8.

Early Outcomes After Heart Transplantation in Recipients Bridged With a HeartMate 3 Device.

Suarez-Pierre A, Lui C, Zhou X, Crawford TC, Fraser CD 3rd, Giuliano K, Hsu S, Higgins RS, Zehr KJ, Whitman GJ, Choi CW, Kilic A.

Ann Thorac Surg. 2019 Aug;108(2):467-473. doi: 10.1016/j.athoracsur.2019.01.084. Epub 2019 Mar 14.

PMID:
30880137
9.

Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study.

Mehra MR, Salerno C, Cleveland JC, Pinney S, Yuzefpolskaya M, Milano CA, Itoh A, Goldstein DJ, Uriel N, Gulati S, Pagani FD, John R, Adamson R, Bogaev R, Thohan V, Chuang J, Sood P, Goates S, Silvestry SC.

Circulation. 2018 Oct 30;138(18):1923-1934. doi: 10.1161/CIRCULATIONAHA.118.035722.

PMID:
29807933
10.

Do patients with the centrifugal flow HeartMate 3 or HeartWare left ventricular assist device have better outcomes compared to those with axial flow HeartMate II?

Florisson DS, Conte SM, De Bono JA, Newcomb AE.

Interact Cardiovasc Thorac Surg. 2019 Dec 1;29(6):844-851. doi: 10.1093/icvts/ivz202.

PMID:
31436825
11.

Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model.

Sutcliffe P, Connock M, Pulikottil-Jacob R, Kandala NB, Suri G, Gurung T, Grove A, Shyangdan D, Briscoe S, Maheswaran H, Clarke A.

Health Technol Assess. 2013 Nov;17(53):1-499, v-vi. doi: 10.3310/hta17530. Review.

12.

Thromboresistance comparison of the HeartMate II ventricular assist device with the device thrombogenicity emulation- optimized HeartAssist 5 VAD.

Chiu WC, Girdhar G, Xenos M, Alemu Y, Soares JS, Einav S, Slepian M, Bluestein D.

J Biomech Eng. 2014 Feb;136(2):021014.

13.

Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.

Goldstein DJ, Naka Y, Horstmanshof D, Ravichandran AK, Schroder J, Ransom J, Itoh A, Uriel N, Cleveland JC Jr, Raval NY, Cogswell R, Suarez EE, Lowes BD, Kim G, Bonde P, Sheikh FH, Sood P, Farrar DJ, Mehra MR.

JAMA Cardiol. 2020 Jan 15. doi: 10.1001/jamacardio.2019.5323. [Epub ahead of print]

PMID:
31939996
14.

Device exchange from HeartMate II to HeartMate 3 left ventricular assist device.

Takeda K, Takayama H, Sanchez J, Cevasco M, Yuzefpolskaya M, Colombo PC, Naka Y.

Interact Cardiovasc Thorac Surg. 2019 Sep 1;29(3):430-433. doi: 10.1093/icvts/ivz113.

PMID:
31143932
15.

Use of left ventricular assist device (HeartMate II): a Singapore experience.

Lim CP, Sivathasan C, Tan TE, Lim CH, Kerk KL, Sim DK.

Artif Organs. 2014 Jul;38(7):543-8. doi: 10.1111/aor.12247. Epub 2014 Jan 7.

PMID:
24392937
16.

Clinical outcomes after ventricular assist device implantation in adults with complex congenital heart disease.

Shah NR, Lam WW, Rodriguez FH 3rd, Ermis PR, Simpson L, Frazier OH, Franklin WJ, Parekh DR.

J Heart Lung Transplant. 2013 Jun;32(6):615-20. doi: 10.1016/j.healun.2013.03.003. Epub 2013 Mar 27.

PMID:
23540399
17.

Evaluation of the ventricular assist device programme in the UK.

Sharples L, Buxton M, Caine N, Cafferty F, Demiris N, Dyer M, Freeman C.

Health Technol Assess. 2006 Nov;10(48):1-119, iii-iv. Review.

18.

Ethical challenges with the left ventricular assist device as a destination therapy.

Rizzieri AG, Verheijde JL, Rady MY, McGregor JL.

Philos Ethics Humanit Med. 2008 Aug 11;3:20. doi: 10.1186/1747-5341-3-20.

19.

Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study.

Colombo PC, Mehra MR, Goldstein DJ, Estep JD, Salerno C, Jorde UP, Cowger JA, Cleveland JC Jr, Uriel N, Sayer G, Skipper ER, Downey FX, Ono M, Hooker R Jr, Anyanwu AC, Givertz MM, Mahr C, Topuria I, Somo SI, Crandall DL, Horstmanshof DA.

Circulation. 2019 Jan 8;139(2):155-168. doi: 10.1161/CIRCULATIONAHA.118.037231.

PMID:
30586698
20.

In Vitro Hemocompatibility Evaluation of Ventricular Assist Devices in Pediatric Flow Conditions: A Benchmark Study.

Chan CHH, Diab S, Moody K, Frazier OH, Sampaio LC, Fraser CD Jr, Teruya J, Adachi I.

Artif Organs. 2018 Nov;42(11):1028-1034. doi: 10.1111/aor.13165. Epub 2018 Aug 12.

PMID:
30101559

Supplemental Content

Support Center